IGXT SEC-arkivering - IntelGenx Technologies Corp.- Årsrapport, fuldmagtserklæring, prospekt

Grundlæggende statistik

CIK

1098880

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to IntelGenx Technologies Corp.

SEC Filings (Chronological Order)

Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.

February 28, 2025	8-K	Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Bankruptcy or Receivership UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2025 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Emplo
October 7, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2024 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employe
August 14, 2024	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ x ] Form 10-Q [ ] Form 10-D [ ] Form N-CEN [ ] Form N-CSR For Period Ended: June 30, 2024 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q F
July 23, 2024	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2024 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer
July 8, 2024	S-8 POS	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	POS AM	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	S-8 POS	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	S-8 POS	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	POS AM	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	S-8 POS	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	POS AM	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	POS AM	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	S-8 POS	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	POS AM	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	POS AM	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	S-8 POS	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	POS AM	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	POS AM	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	S-8 POS	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
July 8, 2024	S-8 POS	As filed with the Securities and Exchange Commission on July 8, 2024 As filed with the Securities and Exchange Commission on July 8, 2024 Registration No.
June 7, 2024	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2024 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer o
May 24, 2024	1-A-W	May 24, 2024 May 24, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.
May 21, 2024	EX-99.1	IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives MONTREAL, May 17, 2024, Québec -(BUSINESS WIRE)- IntelGenx Technologies Corp.
May 21, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2024 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer o
May 15, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TECHNOL
May 8, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer of
May 3, 2024	SC 13D/A	IGXT / IntelGenx Technologies Corp. / ATAI Life Sciences B.V. - SC 13D/A Activist Investment SC 13D/A 1 d835288dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* IntelGenx Technologies Corp. (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class of Securities) 45822R101 (CUSIP Number) Ryan Barrett ATAI Life Sciences AG Wallstraße 16, 10179 Berlin, German
April 12, 2024	253G2	Offering Circular (Post-Qualification Amendment No. 1), Dated April 11, 2024 INTELGENX TECHNOLOGIES CORP. 6420 Abrams Ville Saint Laurent, Quebec H4S 1Y2, Canada (514) 331-7440 BEST EFFORTS OFFERING OF UP TO 2,000,000 SHARES OF SERIES A CONVERTIBLE C Filed pursuant to Rule 253(g)(2) File No. 024-12386 Offering Circular (Post-Qualification Amendment No. 1), Dated April 11, 2024 INTELGENX TECHNOLOGIES CORP. 6420 Abrams Ville Saint Laurent, Quebec H4S 1Y2, Canada (514) 331-7440 www.intelgenx.com BEST EFFORTS OFFERING OF UP TO 2,000,000 SHARES OF SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK AND UP TO 40,000,000 SHARES OF COMMON STOCK INTO WHICH
April 5, 2024	EX1A-11 CONSENT	Consent of Independent Registered Public Accounting Firm Consent of Independent Registered Public Accounting Firm We consent to the use in the Offering Circular constituting a part of this Offering Statement on Post-Qualification Amendment No.
April 5, 2024	PART II AND III	POST QUALIFICATION AMENDMENT TO OFFERING CIRCULAR EXPLANATORY NOTE POST QUALIFICATION AMENDMENT TO OFFERING CIRCULAR EXPLANATORY NOTE This post-qualification amendment no.
March 25, 2024	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2024 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer
March 25, 2024	EX-4.1	Form of Common Stock Purchase Warrant THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "U.
March 25, 2024	EX-10.1	Third Amended and Restated Loan Agreement by and among IntelGenx Technologies Corp., IntelGenx Corp. and ATAI Life Sciences AG, dated March 11, 2024 THIRD AMENDED AND RESTATED LOAN AGREEMENT This THIRD AMENDED AND RESTATED LOAN AGREEMENT, dated as of March 8, 2024 (as amended, restated, modified and/or supplemented, from time to time, this "Agreement"), amending and restating the Amended and Restated Loan Agreement originally effective as of March 8, 2021 and as amended and restated as of September 14, 2021, and further amended and restated as of September 30, 2023 (the "Existing Agreement"), is made by and among INTELGENX CORP.
March 21, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin
March 21, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31187 IntelGenx Technologies Cor
March 12, 2024	EX-99.14	AMENDMENT TO SUBSCRIPTION AGREEMENT EX-99.14 2 d757113dex9914.htm EX-99.14 Exhibit 99.14 AMENDMENT TO SUBSCRIPTION AGREEMENT THIS AMENDMENT TO SUBSCRIPTION AGREEMENT (this “Amendment”) is made as of September 30, 2023 by and among IntelGenx Technologies Corp. (the “Issuer”) and atai Life Sciences AG (the “Subscriber”). RECITALS: WHEREAS the Issuer and the Subscriber entered into that certain subscription agreement dated August 31, 2
March 12, 2024	SC 13D/A	IGXT / IntelGenx Technologies Corp. / ATAI Life Sciences B.V. - SC 13D/A Activist Investment SC 13D/A 1 d757113dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* IntelGenx Technologies Corp. (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class of Securities) 45822R101 (CUSIP Number) Ryan Barrett ATAI Life Sciences AG Wallstraße 16, 10179 Berlin, German
March 12, 2024	EX-99.15	THIRD AMENDED AND RESTATED LOAN AGREEMENT EX-99.15 3 d757113dex9915.htm EX-99.15 Exhibit 99.15 THIRD AMENDED AND RESTATED LOAN AGREEMENT This THIRD AMENDED AND RESTATED LOAN AGREEMENT, dated as of March 8, 2024 (as amended, restated, modified and/or supplemented, from time to time, this “Agreement”), amending and restating the Amended and Restated Loan Agreement originally effective as of March 8, 2021 and as amended and restated as of Se
February 20, 2024	EX-1.1	Selling Agency Agreement, dated February 14, 2024, between IntelGenx Technologies Corp. and Digital Offering, LLC IntelGenx Technologies Corp. Maximum: 2,000,000 Shares of Series A Convertible Cumulative Preferred Stock $0.00001 par value per share SELLING AGENCY AGREEMENT February 14, 2024 Digital Offering, LLC 1461 Glenneyre Street, Suite D Laguna Beach, CA 92651 Dear Ladies and Gentlemen: IntelGenx Technologies Corp., a Delaware corporation (the "Company"), proposes, subject to the terms and conditions con
February 20, 2024	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 (February 14, 2024) INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (C
February 20, 2024	253G2	Offering Circular Dated February 20, 2024 INTELGENX TECHNOLOGIES CORP. 6420 Abrams Ville Saint Laurent, Quebec H4S 1Y2, Canada (514) 331-7440 BEST EFFORTS OFFERING OF UP TO 2,000,000 SHARES OF SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK AND UP TO Filed pursuant to Rule 253(g)(2) File No. 024-12386 Offering Circular Dated February 20, 2024 INTELGENX TECHNOLOGIES CORP. 6420 Abrams Ville Saint Laurent, Quebec H4S 1Y2, Canada (514) 331-7440 www.intelgenx.com BEST EFFORTS OFFERING OF UP TO 2,000,000 SHARES OF SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK AND UP TO 40,000,000 SHARES OF COMMON STOCK INTO WHICH THE SERIES A PREFERRED STOCK MAY C
February 15, 2024	EX1A-3 HLDRS RTS	CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK INTELGENX TECHNOLOGIES CORP. PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK OF INTELGENX TECHNOLOGIES CORP.
February 15, 2024	EX1A-12 OPN CNSL	February 14, 2024 Exhibit 12.1 February 14, 2024 IntelGenx Technologies Corp. 6420 Abrams, Ville Saint Laurent, Quebec, Canada, H4S 1Y2 Ladies and Gentlemen: We have acted as legal counsel to IntelGenx Technologies Corp., a Delaware corporation (the "Company"), in connection with the preparation and filing with the United States Securities and Exchange Commission (the "Commission") of a Form 1-A Regulation A Offeri
February 15, 2024	PART II AND III	Preliminary Offering Circular, Dated February 14, 2024 Preliminary Offering Circular, Dated February 14, 2024 AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.
February 15, 2024	EX1A-11 CONSENT	Consent of Independent Registered Public Accounting Firm Consent of Independent Registered Public Accounting Firm We consent to the use in the Offering Circular constituting a part of this Offering Statement on Form 1-A, as it may be amended, of our audit report dated March 29, 2023 with respect to the consolidated balance sheets of IntelGenx Technologies Corp.
February 15, 2024	EX1A-1 UNDR AGMT	IntelGenx Technologies Corp. Maximum: 2,000,000 Shares of Series A Convertible Cumulative Preferred Stock $0.00001 par value per share SELLING AGENCY AGREEMENT IntelGenx Technologies Corp. Maximum: 2,000,000 Shares of Series A Convertible Cumulative Preferred Stock $0.00001 par value per share SELLING AGENCY AGREEMENT February 14, 2024 Digital Offering, LLC 1461 Glenneyre Street, Suite D Laguna Beach, CA 92651 Dear Ladies and Gentlemen: IntelGenx Technologies Corp., a Delaware corporation (the "Company"), proposes, subject to the terms and conditions con
February 15, 2024	EX1A-4 SUBS AGMT	PUBLIC OFFERING SUBSCRIPTION AGREEMENT SHARES OF SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK INTELGENX TECHNOLOGIES CORP. PUBLIC OFFERING SUBSCRIPTION AGREEMENT SHARES OF SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK of INTELGENX TECHNOLOGIES CORP.
February 15, 2024	EX1A-6 MAT CTRCT	SERIES A CONVERTIBLE CUMULATIVE PREFFERED STOCK PURCHASE WARRANT For the Purchase of [] Shares of Series A Convertible Cumulative Preferred Stock IntelGenx Technologies Corp. THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES BY ITS ACCEPTANCE HEREOF, THAT SUCH HOLDER WILL NOT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING [], 2024, WHICH IS THE CLOSING DATE OF THE OFFERING OF SHARES OF SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK TO WHICH THIS WARRANT RELATES: (A) SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT TO ANYONE OTHER THAN
February 15, 2024	EX1A-4 SUBS AGMT	PUBLIC OFFERING SUBSCRIPTION AGREEMENT SHARES OF SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK INTELGENX TECHNOLOGIES CORP. PUBLIC OFFERING SUBSCRIPTION AGREEMENT SHARES OF SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK of INTELGENX TECHNOLOGIES CORP.
February 15, 2024	EX1A-8 ESCW AGMT	ESCROW AGREEMENT ESCROW AGREEMENT This ESCROW AGREEMENT (this "Agreement") dated as of this 10th day of January 2024 by and among IntelGenx Technologies Corp.
February 14, 2024	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2024 ( February 8, 2024 ) INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (
February 14, 2024	CORRESP	February 14, 2024 February 14, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F.
February 14, 2024	EX-3.1	Certificate of Designations of Preferences, Rights and Limitations of Series A Convertible Cumulative Preferred Stock dated February 8, 2024 CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE CUMULATIVE PREFERRED STOCK OF INTELGENX TECHNOLOGIES CORP.
January 9, 2024	EX1A-11 CONSENT	CONSENT OF INDEPENDENT AUDITOR CONSENT OF INDEPENDENT AUDITOR We consent to the use in the Offering Circular constituting a part of this Offering Statement on Form 1-A, as it may be amended, of our audit report dated March 29, 2023 with respect to the consolidated balance sheets of IntelGenx Technologies Corp.
January 9, 2024	PART II AND III	Preliminary Offering Circular, Dated [], 2024 Preliminary Offering Circular, Dated [], 2024 AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.
January 9, 2024	EX1A-1 UNDR AGMT	SELLING AGENCY AGREEMENT Member FINRA/SIPC 1461 Glenneyre Street, Suite D Laguna Beach, CA 92651 Phone (866) 209-1955 SELLING AGENCY AGREEMENT December 4, 2023 IntelGenx Technologies Corp.
January 9, 2024	EX1A-1 UNDR AGMT	SELLING AGENCY AGREEMENT AMENDMENT Member FINRA/SIPC 1461 Glenneyre Street, Suite D Laguna Beach, CA 92651 Phone (866) 209-1955 SELLING AGENCY AGREEMENT AMENDMENT December 12, 2023 IntelGenx Technologies Corp.
December 11, 2023	EX-FILING FEES	Filing Fee Table Calculation of Filing Fee Tables Form S-8 (Form Type) IntelGenx Technologies Corp.
December 11, 2023	S-8	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact name of registrant as specified in its charter) Delaware 87-0638336 (State or other jurisdiction of Incorporation or organization) 6420 Abrams Ville Saint Laurent, Quebec H4S 1Y2, Canada (Address of principal executive offices)
December 4, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employ
November 28, 2023	EX-3.1	Amendment to the Certificate of Incorporation (incorporated by reference to the Form 8-K filed on November 28, 2023) CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF INTELGENX TECHNOLOGIES CORP.
November 28, 2023	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Emplo
November 9, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TEC
October 16, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin
October 12, 2023	EX-10.2	Exhibit 10.2 SECOND AMENDED AND RESTATED LOAN AGREEMENT This SECOND AMENDED AND RESTATED LOAN AGREEMENT, dated as of September 30, 2023 (as amended, restated, modified and/or supplemented, from time to time, this "Agreement"), amending and restating the Amended and Restated Loan Agreement originally effective as of March 8, 2021 and as amended and restated as of September 14, 2021 (the "Existing Agreement"), is made by and among INTELGENX CORP.
October 12, 2023	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employe
October 6, 2023	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
September 7, 2023	SC 13D/A	IGXT / IntelGenx Technologies Corp / ATAI Life Sciences B.V. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* IntelGenx Technologies Corp. (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class of Securities) 45822R101 (CUSIP Number) Ryan Barrett ATAI Life Sciences AG Wallstraße 16, 10179 Berlin, Germany +49 (0) 89 2153 9035 (Name,
September 7, 2023	EX-99.8	INTELGENX TECHNOLOGIES CORP. (A Delaware Corporation) SUBSCRIPTION DOCUMENTS EX-99.8 Exhibit 99.8 INTELGENX TECHNOLOGIES CORP. (A Delaware Corporation) SUBSCRIPTION DOCUMENTS SUBSCRIPTION AGREEMENT INTELGENX TECHNOLOGIES CORP. Gentlemen (Ladies): The undersigned (the “Subscriber”) hereby tenders this subscription and applies for the purchase of 2,220 units (the “Initial Units”) of IntelGenx Technologies Corp., a Delaware corporation (the “Issuer”), with each Initial Unit c
September 7, 2023	EX-99.9	- 2 - EX-99.9 Certain information contained in this document, marked by [***], has been omitted because it is both (i) not material and (ii) is the type that the reporting person treats as private or confidential. Exhibit 99.9 AGREEMENT This letter agreement (this “Agreement”) is dated August 31, 2023 among ATAI Life Sciences AG (“ATAI”), IntelGenx Technologies Corp. (the “Company”) and IntelGenx Corp.
August 31, 2023	EX-4.1	Exhibit 4.1 THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "U.
August 31, 2023	EX-10.2	Exhibit 10.2 FIRST AMENDMENT TO AMENDED AND RESTATED LOAN AGREEMENT THIS FIRST AMENDMENT TO AMENDED AND RESTATED LOAN AGREEMENT (this "Agreement") is made and entered into as of August 31, 2023, by and among IntelGenx Corp.
August 31, 2023	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employe
August 31, 2023	EX-10.1	Exhibit 10.1 THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "U.
August 14, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TECHNOLO
July 21, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer
May 11, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TECHNOL
May 10, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer of
April 18, 2023	EX-10.1	Employment Agreement between IntelGenx Corp. and Dwight Gorham dated April 13, 2023 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of April 13, 2023: BETWEEN: INTELGENX CORP.
April 18, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer
April 10, 2023	EX-4.7	2022 Amended and Restated Stock Option Plan (filed herewith) INTELGENX TECHNOLOGIES CORP. 2022 AMENDED AND RESTATED STOCK OPTION PLAN May 10, 2022 WHEREAS, IntelGenx Technologies Corp., a Delaware corporation (the "Company") originally adopted its 2006 Stock Option Plan (the "2006 Stock Option Plan") on August 10, 2006. At a meeting of the Board (as defined below) held on May 10, 2016, the Board approved, the adoption of an amended 2006 Stock Option Plan, r
April 10, 2023	S-8	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact name of registrant as specified in its charter) Delaware 87-0638336 (State or other jurisdiction of Incorporation or organization) 6420 Abrams Saint Laurent, Quebec H4S 1Y2, Canada (Address of principal executive offices) (I.R.
April 10, 2023	EX-FILING FEES	Filing Fee Table Calculation of Filing Fee Tables Form S-8 (Form Type) IntelGenx Technologies Corp.
March 29, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defini
March 29, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31187 IntelGenx Technologies Cor
March 27, 2023	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): Mar UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employ
March 24, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer
March 24, 2023	EX-10.1	Form of Note (incorporated by reference to the Form 8-K filed on March 24, 2023) THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "U.
March 24, 2023	EX-10.1	Memorandum of Agreement between IntelGenx Corp. and David Kideckel dated March 20, 2023 MEMORANDUM OF AGREEMENT executed in Montreal, Quebec, this 20th day of March, 2023.
March 24, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer
February 21, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): Febru UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2023 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Emplo
November 10, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TEC
August 11, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TECHNOLO
July 6, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2022 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer
May 12, 2022	10-Q	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TECHNOL
May 11, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer o
April 20, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi
March 24, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31187 IntelGenx Technologies Cor
March 24, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defini
March 21, 2022	EX-3.1	Third Amended and Restated By-Laws (incorporated by reference to the Form 8-K filed on March 21, 2022) THIRD AMENDED AND RESTATED BY-LAWS OF INTELGENX TECHNOLOGIES CORP. (f/k/a/ Big Flash Corporation) (as amended on March 18, 2022) ARTICLE 1 - OFFICES 1.1 REGISTERED OFFICE. The registered office shall be in the City of Wilmington, County of New Castle, State of Delaware. 1.2 OTHER OFFICES. The corporation may also have offices at such other places both within or without the State of Delaware as the
March 21, 2022	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2022 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employer
December 8, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2021 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Employ
December 8, 2021	EX-99.1	IntelGenx Initiates Arbitration Proceeding Against Tilray® Related to an Alleged Breach of Worldwide Cannabis-Infused VersaFilm® Agreement IntelGenx Initiates Arbitration Proceeding Against Tilray? Related to an Alleged Breach of Worldwide Cannabis-Infused VersaFilm? Agreement Saint Laurent, Quebec, December 8, 2021 - IntelGenx Corp.
November 12, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TEC
September 15, 2021	8-K	Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 14, 2021 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commission (IRS Empl
August 11, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 (August 5, 2021) INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 000-31187 87-0638336 (State or other jurisdiction (Commis
August 11, 2021	EX-10.1	Form of Note (incorporated by reference to the Form 8-K filed on August 11, 2021) THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "U.
August 4, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 [ ] TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TECHNOLO
August 4, 2021	EX-10.1	Form of Additional Unit Warrant dated May 14, 2021 (incorporated by reference to the Form 10-Q filed on August 4, 2021) UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE SEPTEMBER 15, 2021.
August 4, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 4, 2021 (August 2, 2021) Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 870638336 (State or other jurisdiction of incorpo
August 4, 2021	EX-10.2	Securities Purchase Agreement - Form of Additional Warrant Certificate UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE SEPTEMBER 15, 2021.
August 4, 2021	EX-10.3	Form of Initial Warrant dated May 14, 2021 (incorporated by reference to the Form 10-Q filed on August 4, 2021) UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE SEPTEMBER 15, 2021.
May 25, 2021	8-K	Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 24, 2021 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 870638336 (State or other jurisdiction of incorporation) (Commission
May 25, 2021	EX-10.1	Amendment No. 1 to 6% Subordinated Convertible Unsecured Promissory Note dated May 24, 2021 (incorporated by reference to the Form 8-K filed on May 25, 2021) Execution Version AMENDMENT NO. 1 TO 6% SUBORDINATED CONVERTIBLE UNSECURED PROMISSORY NOTE This Amendment No. 1 to 6% Subordinated Convertible Unsecured Promissory Note (this "Amendment") is entered into on May 24, 2021 and made effective as of June 1, 2021, by and among IntelGenx Technologies Corp., a Delaware corporation (the "Company"), and the Investors. RECITALS WHEREAS, the Company has issue
May 24, 2021	EX-99.5	COMMON STOCK PURCHASE WARRANT INTELGENX TECHNOLOGIES CORP. Warrant Shares: 22,380,000 Issue Date: May 14, 2021 Exhibit 99.5 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE SEPTEMBER 15, 2021. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE ON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE ?U.S. SECURITIES ACT?). THESE SECURITIES MAY BE OFFERED, SOLD, PLEDGED
May 24, 2021	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT This will confirm the agreement among the undersigned that the Schedule 13D filed on or about this date and any amendments thereto with respect to beneficial ownership by the undersigned of the shares of common stock of IntelGenx Technologies Corp. is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(1) under the Securities Exchan
May 24, 2021	SC 13D	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* IntelGenx Technologies Corp. (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* IntelGenx Technologies Corp. (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class of Securities) 45822R101 (CUSIP Number) Ryan Barrett ATAI Life Sciences AG Krausenstraße 9-10 10117 Berlin, Germany +49 (0) 89 2153 9035 (Name,
May 17, 2021	EX-10.1	Amended and Restated Securities Purchase Agreement dated May 14, 2021 (incorporated by reference to the Form 8-K filed on May 17, 2021) AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT between ATAI LIFE SCIENCES AG - and - INTELGENX TECHNOLOGIES CORP.
May 17, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 14, 2021 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 870638336 (State or other jurisdiction of incorporation) (Commission
May 17, 2021	EX-10.2	First Amendment to Loan Agreement dated May 14, 2021 (incorporated by reference to the Form 8-K filed on May 17, 2021) FIRST AMENDMENT TO LOAN AGREEMENT This First Amendment (this "Amendment") to the Loan Agreement dated as of March 8, 2021 among IntelGenx Corp.
May 13, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TECHNOL
May 12, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 11, 2021 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 870638336 (State or other jurisdiction of incorporation) (Commission
April 5, 2021	DEF 14A	- FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defini
March 26, 2021	PRER14A	- PRER14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defini
March 25, 2021	EX-10.26	Loan Agreement dated March 9, 2021 (incorporated by reference to the Form 10-K filed on March 25, 2021) Execution Version LOAN AGREEMENT This LOAN AGREEMENT, dated as of March 8, 2021 (as amended, restated, modified and/or supplemented, from time to time, this "Agreement") is made by and among INTELGENX CORP.
March 25, 2021	EX-10.28	Securities Purchase Agreement dated March 14, 2021(incorporated by reference to the Form 10-K filed on March 25, 2021) Execution Version SECURITIES PURCHASE AGREEMENT between ATAI LIFE SCIENCES AG - and - INTELGENX TECHNOLOGIES CORP.
March 25, 2021	10-K	Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31187 IntelGenx Technologies Cor
March 25, 2021	PRE 14A	- FORM PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defini
March 25, 2021	EX-10.27	Strategic Development Agreement dated March 14, 2021(incorporated by reference to the Form 10-K filed on March 25, 2021) , Certain identified information in this document has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed, and has been marked with "[***]" to indicate where omissions have been made.
March 25, 2021	EX-10.29	Purchaser Rights Agreement dated March 14, 2021(incorporated by reference to the Form 10-K filed on March 25, 2021) Execution Version PURCHASER RIGHTS AGREEMENT Between ATAI LIFE SCIENCES AG - and - INTELGENX TECHNOLOGIES CORP.
March 15, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 9, 2021 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 870638336 (State or other jurisdiction of incorporation) (Commissio
March 15, 2021	EX-99.1	IntelGenx Announces Strategic Partnership with atai Life Sciences and Proposed TSX Graduation IntelGenx Announces Strategic Partnership with atai Life Sciences and Proposed TSX Graduation SAINT LAURENT, Quebec, and NEW YORK, New York, March 15, 2021 - IntelGenx Technologies Corp.
January 14, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 11, 2021 Date of Report (Date of Earliest Event Reported) INTELGENX TECHNOLOGIES CORP. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 870638336 (State or other jurisdiction of incorporation) (Commis
January 14, 2021	EX-99.1	IntelGenx Appoints Tommy Kenny as Vice President, Intellectual Property and Legal Affairs, General Counsel EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 IntelGenx Appoints Tommy Kenny as Vice President, Intellectual Property and Legal Affairs, General Counsel Saint Laurent, Quebec, January 12, 2021 - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) ("IntelGenx" or the "Company") today announced that its Board of Directors appointed Mr. Tommy Kenny as Vice President, Intellectual Property and Legal Affai
January 5, 2021	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 31, 2020 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 870638336 (State or other jurisdiction of incorporation) (Commi
December 23, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 25, 2020 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 870638336 (State or other jurisdiction of incorporation) (Commissio
December 23, 2020	EX-4.1	Second Supplemental Trust Indenture, June 25, 2020.(incorporated by reference to the Form 8-K on December 23, 2020) EX-4.1 2 exhibit4-1.htm EXHIBIT 4.1 SECOND SUPPLEMENTAL TRUST INDENTURE TO THE TRUST INDENTURE DATED AS OF JULY 12, 2017 between INTELGENX TECHNOLOGIES CORP. and TSX Trust Company Dated as of June 25, 2020 TABLE OF CONTENTS Article 1 INTERPRETATION 3 1.1 To Be Read with Indenture 3 1.2 Definitions 4 Article 2 AMENDMENTS TO THE INDENTURE 4 2.1 Amendments 4 Article 3 CONCERNING THIS TRUST INDENTURE
December 23, 2020	EX-99.1	IntelGenx Announces Approval of Proposed Amendments to Convertible Debentures IntelGenx Announces Approval of Proposed Amendments to Convertible Debentures SAINT LAURENT, Quebec, June 25, 2020 - IntelGenx Technologies Corp.
November 12, 2020	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TEC
October 28, 2020	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 23, 2020 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 870638336 (State or other jurisdiction of incorporation) (Commis
October 28, 2020	EX-99.1	INTELGENX ANNOUNCES SECOND TRANCHE CLOSING OF PRIVATE PLACEMENT INTELGENX ANNOUNCES SECOND TRANCHE CLOSING OF PRIVATE PLACEMENT Saint Laurent, Quebec (October 23, 2020) - IntelGenx Technologies Corp.
October 21, 2020	EX-10.1	Form of Note THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "US SECURITIES ACT"), OR UNDER ANY OTHER APPLICABLE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED EXCEPT (A) PURSUANT TO A REGISTRATION STATEMENT EFFECTIVE UNDER THE US SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, OR (B) PURSUANT TO AN EXEMPTION FROM SUCH REGISTRATION.
October 21, 2020	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 15, 2020 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 870638336 (State or other jurisdiction of incorporation) (Commis
October 21, 2020	EX-99.1	INTELGENX CLOSES U.S. $1.2 MILLION PRIVATE PLACEMENT FINANCING INTELGENX CLOSES U.S. $1.2 MILLION PRIVATE PLACEMENT FINANCING Saint Laurent, Quebec (October 15, 2020) - IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") announces the closing of an offering by way of private placement (the "Offering") to certain investors in the United States of U.S.$1.2 million principal amount of 8% convertible notes due October 15, 2024 (th
August 13, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TECHNOLO
July 17, 2020	EX-99.1	IntelGenx Reports Amendment of Stock Option Plan IntelGenx Reports Amendment of Stock Option Plan Saint Laurent, Quebec, July 15, 2020 - IntelGenx Technologies Corp.
July 17, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 16, 2020 INTELGENX TECHNOLOGIES CORP.
July 17, 2020	EX-4.1	Second Amended 2016 Stock Option Plan, July 16, 2020 (incorporated by reference to the Form 8-K on July 17, 2020) INTELGENX TECHNOLOGIES CORP. SECOND AMENDED 2016 STOCK OPTION PLAN SECTION 1. PURPOSE The purpose of this 2016 Stock Option Plan (the "Plan") of IntelGenx Technologies Corp., a Delaware corporation (the "Company"), is to provide additional incentives to key individuals who are primarily responsible for the management, success and growth of the Company by offering selected directors, officers, empl
June 3, 2020	8-K/A	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A (Amendment No.
May 14, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TECHNOL
May 13, 2020	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2020 IntelGenx Technologies Corp.
April 27, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 23, 2020 INTELGENX TECHNOLOGIES CORP.
April 23, 2020	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
April 15, 2020	10-K/A	IGXT / IntelGenx Technologies Corp. 10-K/A - Annual Report - FORM 10K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31187 In
March 26, 2020	10-K	IGXT / IntelGenx Technologies Corp. 10-K - Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31187 INTELGENX TECHNOLOGIES
March 26, 2020	EX-4.3	Description of the Company's Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (incorporated by reference to the Form 10-K filed on March 26, 2020) Exhibit 4.3 DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of the date of the Annual Report on Form 10-K of which this Exhibit 4.3 is a part, IntelGenx Technologies Corp. (the "Company", "we", "us" or "our") has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: the Company'
March 26, 2020	DEF 14A	IGXT / IntelGenx Technologies Corp. DEF 14A - - FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
February 12, 2020	EX-4.1	Warrant Indenture dated February 11, 2020 (incorporated by reference to the Form 8-K filed on February 12, 2020) WARRANT INDENTURE Providing for the Issue of Common Share Purchase Warrants BETWEEN INTELGENX TECHNOLOGIES CORP.
February 12, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 11, 2020 (February 11, 2020) INTELGENX TECHNOLOGIES CORP.
January 30, 2020	S-1/A	Form of Agent Warrant (incorporated by reference to the Form S-1/A on filed on January 30, 2020) As filed with the Securities and Exchange Commission on January 30, 2020 Registration Statement No.
January 30, 2020	CORRESP	IGXT / IntelGenx Technologies Corp. CORRESP - - January 30, 2020 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance Attn: Ada D.
January 29, 2020	EX-99.1	TERM SHEET INTELGENX TECHNOLOGIES CORP. OFFERING OF UNITS JANUARY 27, 2020 TERM SHEET INTELGENX TECHNOLOGIES CORP. OFFERING OF UNITS JANUARY 27, 2020 The issuer has filed a registration statement (including a prospectus) with the United States Securities and Exchange Commission ("SEC") for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC
January 29, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 27, 2020 INTELGENX TECHNOLOGIES CORP.
January 29, 2020	EX-1.1	Agency Agreement dated January 27, 2020 (incorporated by reference to the Form 8-K filed on January 29, 2020) AGENCY AGREEMENT January 27, 2020 IntelGenx Technologies Corp. 6420 Abrams Ville Saint-Laurent, Québec H4S 1Y2 Attention: Horst G. Zerbe, Chief Executive Officer Dear Sir: The undersigned, Echelon Wealth Partners Inc. (the “Agent”) understands that IntelGenx Technologies Corp. (the “Corporation”) proposes to issue and offer for sale up to an aggregate amount of 20,000,000 units of the Corporation
January 28, 2020	EX-1.1	Form of Agency Agreement AGENCY AGREEMENT January 27, 2020 IntelGenx Technologies Corp. 6420 Abrams Ville Saint-Laurent, Québec H4S 1Y2 Attention: Horst G. Zerbe, Chief Executive Officer Dear Sir: The undersigned, Echelon Wealth Partners Inc. (the “Agent”) understands that IntelGenx Technologies Corp. (the “Corporation”) proposes to issue and offer for sale up to an aggregate amount of 20,000,000 units of the Corporation
January 28, 2020	S-1/A	IGXT / IntelGenx Technologies Corp. S-1/A - - S-1/A IntelGenx Technologies Corp.: Form S-1A - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on January 27, 2020 Registration Statement No. 333-235607 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTELGENX TECHNOLOGIES CORP. (Exact Name of Registrant as Specifi
January 28, 2020	EX-10.30	Form of Agent Warrant COMMON STOCK NON-TRANSFERABLE PURCHASE WARRANT INTELGENX TECHNOLOGIES CORP. Warrant Shares: Issue Date: ● , 2020 Initial Exercise Date: ● , 2020 THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, ● (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereo
January 28, 2020	EX-10.29	Form of Warrant Indenture WARRANT INDENTURE Providing for the Issue of Common Share Purchase Warrants BETWEEN INTELGENX TECHNOLOGIES CORP.
January 16, 2020	EX-99.1	TERM SHEET INTELGENX TECHNOLOGIES CORP. OFFERING OF UNITS JANUARY 16, 2020 TERM SHEET INTELGENX TECHNOLOGIES CORP. OFFERING OF UNITS JANUARY 16, 2020 The issuer has filed a registration statement (including a prospectus) with the United States Securities and Exchange Commission ("SEC") for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC
January 16, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 16, 2020 INTELGENX TECHNOLOGIES CORP.
January 10, 2020	EX-99.1	A preliminary short form prospectus containing important information relating to the securities described in this document has been filed with the securities regulatory authorities in British Columbia, Alberta, Manitoba, Ontario and Québec. A copy of IntelGenx Technologies Corp. - Exhibit 99.1 - Filed by newsfilecorp.com Legend A preliminary short form prospectus containing important information relating to the securities described in this document has been filed with the securities regulatory authorities in British Columbia, Alberta, Manitoba, Ontario and Québec. A copy of the preliminary short form prospectus, and any amendment, is required
January 10, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 7, 2020 INTELGENX TECHNOLOGIES CORP.
January 10, 2020	EX-99.2	TERM SHEET INTELGENX TECHNOLOGIES CORP. OFFERING OF UNITS JANUARY 7, 2020 TERM SHEET INTELGENX TECHNOLOGIES CORP. OFFERING OF UNITS JANUARY 7, 2020 The issuer has filed a registration statement (including a prospectus) with the United States Securities and Exchange Commission ("SEC") for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC
December 20, 2019	S-1	IGXT / IntelGenx Technologies Corp. S-1 - Registration Statement - S-1 As filed with the Securities and Exchange Commission on December 19, 2019 Registration Statement No.
November 7, 2019	10-Q	IGXT / IntelGenx Technologies Corp. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TEC
August 8, 2019	10-Q	IGXT / IntelGenx Technologies Corp. 10-Q - Quarterly Report - FORM 10-Q IntelGenx Technologies Corp.: Form 10Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition
May 9, 2019	EX-10.32	Exhibit 10.32+ Amendment to Employment Agreement, Dana Matzen, May 2019 AMENDMENT dated May 6, 2019 to that MEMORANDUM OF AGREEMENT executed on March 1, 2016 ("Amendment").
May 9, 2019	EX-10.29	Exhibit 10.29+ Amendment to Employment Agreement, Horst G. Zerbe, May, 2019 AMENDMENT dated May 1, 2019 to that MEMORANDUM OF AGREEMENT executed on October 1, 2014 and effective July 15, 2014 ("Amendment").
May 9, 2019	EX-10.30	Exhibit 10.30+ Amendment to Employment Agreement, Andre Godin, May 2019 AMENDMENT dated May 1st, 2019 to that MEMORANDUM OF AGREEMENT executed on July 20, 2015 ("Amendment").
May 9, 2019	EX-10.31	Exhibit 10.31+ Amendment to Employment Agreement, Nadine Paiement, May 2019 AMENDMENT dated May 6, 2019 to that MEMORANDUM OF AGREEMENT executed on January 19, 2016 ("Amendment").
May 9, 2019	10-Q	IGXT / IntelGenx Technologies Corp. 10-Q Quarterly Report FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-31187 INTELGENX TECHNOL
May 8, 2019	EX-99.1	IntelGenx Announces the Appointment of André Godin as President and Chief Financial Officer EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 IntelGenx Announces the Appointment of André Godin as President and Chief Financial Officer Saint Laurent, Quebec, May 08, 2019 - IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that its Board of Directors appointed André Godin to the position of President in addition to his current po
May 8, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events IntelGenx Technologies Corp. - Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 7, 2019 Date of Report (Date of Earliest Event Reported) INTELGENX TECHNOLOGIES CORP. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 8
May 7, 2019	8-K	Submission of Matters to a Vote of Security Holders IntelGenx Technologies Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2019 IntelGenx Technologies Corp. (Exact name of registrant as specified in its charter) Delaware 000-31187
April 30, 2019	DEFA14A	IGXT / IntelGenx Technologies Corp. DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
March 22, 2019	DEF 14A	IGXT / IntelGenx Technologies Corp. DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
March 22, 2019	10-K	IGXT / IntelGenx Technologies Corp. FORM 10-K (Annual Report) IntelGenx Technologies Corp. - Form 10-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition peri
March 8, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers IntelGenx Technologies Corp. - Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 28, 2018 Date of Report (Date of Earliest Event Reported) INTELGENX TECHNOLOGIES CORP. (Exact Name of Registrant as Specified in its Charter) Delaware 000-3
February 7, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events Intelgenx Technologies Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 7, 2019 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-311
February 7, 2019	EX-99.1	IntelGenx Strengthens Senior Management Team Intelgenx Technologies Corp.: Exhibit 99.1 - Filed by newsfilecorp.com IntelGenx Strengthens Senior Management Team Saint-Laurent, Canada – February 7, 2019 – IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT), today announced that it has strengthened its management team with the appointment of Dr. Rodolphe Obeid to the position of Vice President, Operations of IntelGenx Corp. Dr. Obeid is an
January 18, 2019	S-1/A	IGXT / IntelGenx Technologies Corp. FORM S-1/A IntelGenx Technologies Corp.: Form S-1/A - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on January 18, 2019 Registration Statement No. 333-229000 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/A (Amendment No.1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact Name of Registrant as Specif
December 21, 2018	S-1	Power of Attorney IntelGenx Technologies Corp.: Form S-1 - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on December 21, 2018 Registration Statement No. [] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware
December 19, 2018	EX-4.6	Amended 2016 Stock Option Plan (December 3, 2018) (incorporated by reference from the Registrant's Form S-8, File No. 333-228901, filed on December 19, 2018) IntelGenx Technologies Corp. - Exhibit 4.6 - Filed by newsfilecorp.com AMENDED INTELGENX TECHNOLOGIES CORP. 2016 STOCK OPTION PLAN SECTION 1. PURPOSE The purpose of this amended 2016 Stock Option Plan (the “Plan”) of IntelGenx Technologies Corp., a Delaware corporation (the “Company”), is to provide additional incentives to key individuals who are primarily responsible for the management, success
December 19, 2018	S-8	IGXT / IntelGenx Technologies Corp. FORM S-8 IntelGenx Technologies Corp. - Form S-8 - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 87-0638336 (State or other jurisdiction of (I.R.S. Employer Incorporation or organization) Identificat
December 18, 2018	8-K	Other Events IntelGenx Technologies Corp. - Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2018 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 00
November 8, 2018	10-Q	IGXT / IntelGenx Technologies Corp. FORM 10-Q (Quarterly Report) IntelGenx Technologies Corp.: Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran
October 20, 2018	EX-4.1	Form of Warrant (incorporated by reference to the Form 8-K on October 22, 2018) IntelGenx Technologies Corp. - Exhibit 4.1 - Filed by newsfilecorp.com COMMON STOCK PURCHASE WARRANT INTELGENX TECHNOLOGIES CORP. Warrant Shares: Issue Date: October , 2018 Initial Exercise Date: October , 2018 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise a
October 20, 2018	EX-1.1	Placement Agent Agreement between the Company and H.C. Wainwright & Co., LLC dated October 18, 2018 (incorporated by reference to the Form 8-K filed on October 22, 2018) IntelGenx Technologies Corp. - Exhibit 1.1 - Filed by newsfilecorp.com U.S. PLACEMENT AGENCY AGREEMENT October 18, 2018 H.C. Wainwright & Co., LLC 430 Park Avenue New York, New York 10022 Ladies and Gentlemen: Subject to the terms and conditions herein (this “Agreement”), IntelGenx Technologies Corp., a Delaware corporation (the “Company”), hereby agrees to sell up to an aggregate of up to $12,001
October 20, 2018	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits IntelGenx Technologies Corp.: Form 8K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2018 IntelGenx Technologies Corp. (Exact name of registrant as specified in its charter) Delaware 000-3
October 20, 2018	EX-10.1	Form of Securities Purchase Agreement (incorporated by reference to the Form 8-K filed on October 22, 2018) IntelGenx Technologies Corp. - Exhibit 10.1 - Filed by newsfilecorp.com SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of October 18, 2018, between IntelGenx Technologies Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collective
October 20, 2018	EX-1.2	Placement Agent Agreement between the Company and Echelon Wealth Partners Inc. dated October 18, 2018 (incorporated by reference to the Form 8-K filed on October 22, 2018) IntelGenx Technologies Corp. - Exhibit 1.2 - Filed by newsfilecorp.com CANADIAN PLACEMENT AGENCY AGREEMENT October 18, 2018 Echelon Wealth Partners Inc. 1 Adelaide Street East, Suite 2100 Toronto, ON M5C 2V9 Ladies and Gentlemen: Subject to the terms and conditions herein (this “Agreement”), IntelGenx Technologies Corp., a Delaware corporation (the “Company”), hereby agrees to sell up to an aggreg
October 19, 2018	424B5	IntelGenx Technologies Corp. 17,144,314 Units Each Unit Consisting of One Share of Common Stock One Half of One Warrant to Purchase One Share of Common Stock IntelGenx Technologies Corp. - Form 424(B)(5) - Filed by newsfilecorp.com Filed Pursuant to Rule 424(b)(5) Registration Statement No. 333-227498 Prospectus Supplement (To Prospectus dated October 4, 2018) IntelGenx Technologies Corp. 17,144,314 Units Each Unit Consisting of One Share of Common Stock and One Half of One Warrant to Purchase One Share of Common Stock We are offering 17,144,314 units
October 17, 2018	424B5	SUBJECT TO COMPLETION, DATED October 17, 2018 IntelGenx Technologies Corp. - Form 424(b)5 - Filed by newsfilecorp.com Filed Pursuant to Rule 424(b)(5) Registration Statement No. 333-227498 The information in this preliminary prospectus supplement is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus suppl
October 17, 2018	8-K	Other Events IntelGenx Technologies Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2018 IntelGenx Technologies Corp. (Exact name of registrant as specified in its charter) Delaware 000-
October 11, 2018	CORRESP	IGXT / IntelGenx Technologies Corp. CORRESP IntelGenx Technologies Corp. - SEC Correspondence - Filed by newsfilecorp.com October 11, 2018 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Request for Acceleration – IntelGenx Technologies Corp. Registration Statement on Form S-3 (SEC File No. 333- 227498) Ladies and Gentlemen: Pursuant to Rule 461 promulg
October 4, 2018	EX-4.1	Form of Indenture IntelGenx Technologies Corp.: Exhibit 4.1 - Filed by newsfilecorp.com INTELGENX TECHNOLOGIES CORP. as Issuer and [ ] as U.S. Trustee and [ ] as Canadian Trustee Indenture Dated as of [ ] TABLE OF CONTENTS ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.01 Definitions 1 SECTION 1.02 Rules of Construction 10 SECTION 1.03 Compliance Certificates and Opinions 10 SECTION
October 4, 2018	S-3/A	IGXT / IntelGenx Technologies Corp. FORM S-3/A IntelGenx Technologies Corp.: Form S-3/A - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on October 4, 2018 Registration Statement No. 333-227498 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact Name of Registrant as Specifi
October 4, 2018	CORRESP	IGXT / IntelGenx Technologies Corp. CORRESP IntelGenx Technologies Corp.: CORRESP - Filed by newsfilecorp.com October 4, 2018 Ada D. Sarmento Division of Corporate Finance Office of Healthcare & Insurance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Responses to the Securities and Exchange Commission Staff Comments dated October 2, 2018, regarding IntelGenx Technologies Corp. Registration Statement on For
September 24, 2018	S-3	IGXT / IntelGenx Technologies Corp. FORM S-3 IntelGenx Technologies Corp.: Form S-3 - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on September 24, 2018 Registration Statement No. [] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delawar
August 9, 2018	10-Q	IGXT / IntelGenx Technologies Corp. FORM 10-Q (Quarterly Report) IntelGenx Technologies Corp.: Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transitio
July 27, 2018	S-8	IGXT / IntelGenx Technologies Corp. S-8 IntelGenx Technologies Corp. Form S-8 - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTELGENX TECHNOLOGIES CORP. (Exact name of registrant as specified in its charter) Delaware 87-0638336 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organiz
July 27, 2018	EX-4.1	IntelGenx Technologies Corp. Performance and Restricted Share Unit Plan IntelGenx Technologies Corp. - Exhibit 4.1 - Filed by newsfilecorp.com APPENDIX B INTELGENX TECHNOLOGIES CORP. PERFORMANCE AND RESTRICTED SHARE UNIT PLAN MAY 08, 2018 IntelGenx Technologies Corp. Performance and Restricted Share Unit Plan ARTICLE 1 PURPOSE 1.1 Purpose The purpose of this Plan is to provide the Corporation with a share-related mechanism to attract, retain and motivate qualified Dir
July 24, 2018	S-1/A	IGXT / IntelGenx Technologies Corp. FORM S-1/A IntelGenx Technologies Corp.: Form S-1/A - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on July 24, 2018 Registration Statement No. 333-226109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/A (Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact Name of Registrant as Specifie
July 24, 2018	CORRESP	IGXT / IntelGenx Technologies Corp. CORRESP IntelGenx Technologies Corp.: Correspondence - Filed by newsfilecorp.com July 24, 2018 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance Attn: Ada D. Sarmento 100 F Street, N.E. Washington, D.C. 20549 Re: Request for Acceleration – IntelGenx Technologies Corp. Amendment No. 1 to Registration Statement on Form S-1 (SEC File N
July 10, 2018	S-1	IGXT / IntelGenx Technologies Corp. FORM S-1 IntelGenx Technologies Corp.: Form S-1 - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on July 10, 2018 Registration Statement No. [] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 283
May 30, 2018	424B3	INTELGENX TECHNOLOGIES CORP. Up to 3,370,902 shares of Common Stock issuable upon exercise of 3,370,902 Warrants IntelGenx Technologies Corp.: Form 424B3 - Filed by newsfilecorp.com Filed pursuant to Rule 424(b)(3) Registration No. 333-190065 PROSPECTUS SUPPLEMENT NO. 1 (to Prospectus dated April 6, 2018) INTELGENX TECHNOLOGIES CORP. Up to 3,370,902 shares of Common Stock issuable upon exercise of 3,370,902 Warrants The prospectus supplement modifies and supplements the prospectus of IntelGenx Technologies C
May 10, 2018	10-Q	IGXT / IntelGenx Technologies Corp. FORM 10-Q (Quarterly Report) IntelGenx Technologies Corp.: Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transiti
May 10, 2018	EX-1.1	Placement Agent Agreement dated May 8, 2018 (incorporated by reference to the Form 8-K filed on May 10, 2018) IntelGenx Technologies Corp.: Exhibit 1.1 - Filed by newsfilecorp.com CANTONE RESEARCH, INC. PLACEMENT AGENT AGREEMENT May 8, 2018 IntelGenx Technologies Corp. 6420 Abrams, Ville St.-Laurent Quebec, Canada H4S 1Y2 RE: Placement Agent Agreement for Units Consisting of Common Stock and Notes of IntelGenx Technologies Corp. Gentlemen: This letter serves as our agreement (the “Agreement”) that IntelGe
May 10, 2018	EX-10.2	Form of Registration Rights Agreement dated May 8, 2018 (incorporated by reference to the Form 8-K filed on May 10, 2018) IntelGenx Technologies Corp.: Exhibit 10.2 - Filed by newsfilecorp.com EXHIBIT A REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 8, 2018, between IntelGenx Technologies Corp., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “P
May 10, 2018	EX-4.1	Form of Warrant dated May 8, 2018 (incorporated by reference to the Form 8-K filed on May 10, 2018) IntelGenx Technologies Corp.: Exhibit 4.1 - Filed by newsfilecorp.com NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT
May 10, 2018	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits IntelGenx Technologies Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 8, 2018 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 87
May 10, 2018	EX-10.1	Form of Securities Purchase Agreement dated May 8, 2018 (incorporated by reference to the Form 8-K filed on May 10, 2018) IntelGenx Technologies Corp.: Exhibit 10.1 - Filed by newsfilecorp.com SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of May 8, 2018, between IntelGenx Technologies Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, th
May 10, 2018	EX-10.3	Form of Note dated May 8, 2018 (incorporated by reference to the Form 8-K filed on May 10, 2018) IntelGenx Technologies Corp.: Exhibit 10.3 - Filed by newsfilecorp.com THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APP
May 9, 2018	8-K	Submission of Matters to a Vote of Security Holders IntelGenx Technologies Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2018 IntelGenx Technologies Corp. (Exact name of registrant as specified in its charter) Delaware 000-31187
April 6, 2018	POS AM	IGXT / IntelGenx Technologies Corp. POS AM Intelgenx Technologies Corp.: Form POS AM - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 10 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTELGENX TECHNOLOGIES CORP. (Exact Name of Registrant as Specified in its Charter) Delaware 2834 87-0638336 (State or other jurisdiction of (Primary Standard
March 29, 2018	DEF 14A	IGXT / IntelGenx Technologies Corp. DEF 14A IntelGenx Technologies Corp. - Schedule DEF14A - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Conf
March 29, 2018	EX-10.25	Deferred Share Unit Plan for non-employee directors IntelGenx Technologies Corp.: Exhibit 10.25 - Filed by newsfilecorp.com INTELGENX TECHNOLOGIES CORP. DEFERRED SHARE UNIT PLAN Section 1. Interpretation and Administrative Provisions 1.1 Purpose The purposes of the Plan are to: (i) align the interests of Directors of the Corporation with the long term interests of shareholders; and (ii) allow the Corporation to attract and retain high quality Direc
March 29, 2018	10-K	IGXT / IntelGenx Technologies Corp. FORM 10-K (Annual Report) IntelGenx Technologies Corp.: Form 10-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr
March 7, 2018	PRE 14A	IGXT / IntelGenx Technologies Corp. PRE 14A IntelGenx Technologies Corp.: Form PRE 14A - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [X] Preliminary Proxy Statement [ ] Confiden
January 26, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers IntelGenx Technologies Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 26, 2018 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-311
December 6, 2017	8-K	Termination of a Material Definitive Agreement, Other Events IntelGenx Technologies Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 5, 2017 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-311
December 6, 2017	EX-99.1	IntelGenx to Regain Exclusive Worldwide Rights to Develop and Commercialize RIZAPORT® - FDA Requests More Information Before Full Review of RIZAPORT® NDA Resubmission - IntelGenx Technologies Corp.: Exhibit 99.1 - Filed by newsfilecorp.com IntelGenx to Regain Exclusive Worldwide Rights to Develop and Commercialize RIZAPORT? - FDA Requests More Information Before Full Review of RIZAPORT? NDA Resubmission - Saint Laurent, Quebec: December 05, 2017 - IntelGenx Corp. (TSXV: IGX; OTCQX: IGXT) (the ?Company? or ?IntelGenx?) today announced it has received notice that R
November 9, 2017	10-Q	IGXT / IntelGenx Technologies Corp. FORM 10-Q (Quarterly Report) IntelGenx Technologies Corp. - Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tra
September 7, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers IntelGenx Technologies Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 31, 2017 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-3118
August 19, 2017	POS AM	IntelGenx Technologies FORM POS AM IntelGenx Corp. - Form S-1/A - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on August 18, 2017 Registration Statement No. 333-190065 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 9 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTELGENX TECHNOLOGIES CORP. (Exact Name of Registrant as Spec
August 10, 2017	EX-10.2	Supplemental Trust Indenture IntelGenx Technologies Corp.: Exhibit 10.2 - Filed by newsfilecorp.com FIRST SUPPLEMENTAL TRUST INDENTURE TO THE TRUST INDENTURE DATED AS OF JULY 12, 2017 between INTELGENX TECHNOLOGIES CORP. and TSX Trust Company providing for the issue of Convertible Unsecured Subordinated Debentures Dated as of August 8, 2017 TABLE OF CONTENTS Article 1 INTERPRETATION 3 1.1 To Be Read with Indenture 3 1.2 Defin
August 10, 2017	CORRESP	IntelGenx Technologies ESP IntelGenx Technologies Corp.: Correspondence - Filed by newsfilecorp.com Richard B. Raymer Partner (416) 367-7388 FAX (416) 367-7371 [email protected] August 10, 2017 Via EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 USA Attention: Irene Paik Assistant Director Division of Corporate Finance Re: IntelGenx Technologies Corp.
August 10, 2017	10-Q	IGXT / IntelGenx Technologies Corp. FORM 10-Q (Quarterly Report) IntelGenx Technologies Corp.: Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transit
August 10, 2017	EX-10.1	Supplemental Agency Agreement IntelGenx Technologies Corp.: Exhibit 10.1 - Filed by newsfilecorp.com THIS SUPPLEMENTAL AGENCY AGREEMENT is made on this 8th day of August, 2017. BETWEEN: (1) IntelGenx Technologies Corp. (the “Corporation”); (2) Desjardins Securities Inc. (the “Lead Agent”); (3) Laurentian Bank Securities Inc. (“Laurentian”); and (4) Echelon Wealth Partners Inc. (“Echelon” and, collectively with the Lead Agent a
August 9, 2017	8-K	Entry into a Material Definitive Agreement IntelGenx Technologies Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 8, 2017 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187
August 2, 2017	POS AM	IntelGenx Technologies POS AM IntelGenx Technologies Corp. - POS AM - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on August 2, 2017 Registration Statement No. 333-190065 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 8 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTELGENX TECHNOLOGIES CORP. (Exact Name of Registrant
July 18, 2017	POS AM	IntelGenx Technologies POS AM IntelGenx Technologies Corp. - POS AM - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on July 18, 2017 Registration Statement No. 333-190065 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 7 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTELGENX TECHNOLOGIES CORP. (Exact Name of Registrant
July 12, 2017	EX-4.1	Trust Indenture with TSX Trust Company, dated July 12, 2017 (incorporated by reference to the Form 8-K filed on July 12, 2017) IntelGenx Technologies Corp.: Exhibit 4.1 - Filed by newsfilecorp.com TRUST INDENTURE between INTELGENX TECHNOLOGIES CORP. and TSX Trust Company providing for the issue of Convertible Unsecured Subordinated Debentures Dated as of July 12, 2017 TABLE OF CONTENTS Page ARTICLE 1 INTERPRETATION 1 1.1 Definitions 1 1.2 Meaning of ?Outstanding? 7 1.3 Interpretation 7 1.4 Headings, etc. 8 1.5 Day Not a B
July 12, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events IntelGenx Technologies Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 12, 2017 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187
July 12, 2017	EX-99.1	IntelGenx Completes CDN$6.8 Million Convertible Debenture Offering IntelGenx Technologies Corp.: Exhibit 99.1 - Filed by newsfilecorp.com IntelGenx Completes CDN$6.8 Million Convertible Debenture Offering Saint Laurent, Quebec, July 12, 2017 - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the ?Corporation? or ?IntelGenx?) is pleased to announce that it has closed its previously announced prospectus offering (the ?Offering?) of convertible unsecured subo
July 7, 2017	S-1/A	As filed with the Securities and Exchange Commission on July 7, 2017 IntelGenx Technologies Corp.: Form S-1 - Filed by newsfilecorp.com As filed with the Securities and Exchange Commission on July 7, 2017 Registration Statement No. 333-217148 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 (Amendment No. 3) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in
July 7, 2017	CORRESP	IntelGenx Technologies ESP IntelGenx Technologies Corp.: CORRESP - Filed by newsfilecorp.com July 7, 2017 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance Attn: Suzanne Hayes, Assistant Director 100 F Street, N.E. Washington, D.C. 20549 Re: Request for Acceleration ? IntelGenx Technologies Corp. Amendment No. 3 to Registration Statement on Form S-1 (
July 7, 2017	CORRESP	IntelGenx Technologies ESP IntelGenx Technologies Corp. - SEC Correspondence - Filed by newsfilecorp.com July 7, 2017 Suzanne Hayes Assistant Director Office of Healthcare and Insurance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Responses to the Securities and Exchange Commission Staff Comments dated July 6, 2017, regarding IntelGenx Technologies Corp. Amendment No. 2 to Registration St
July 5, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits IntelGenx Technologies Corp.: Form 8K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 28, 2017 Date of Report (Date of Earliest Event Reported) IntelGenx Technologies Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 000-31187 8
July 5, 2017	EX-1.1	Agency Agreement dated June 28, 2017 (incorporated by reference from the Company’s Form 8-K filed on July 5, 2017) IntelGenx Technologies Corp.: Exhibit 1.1 - Filed by newsfilecorp.com AGENCY AGREEMENT June 28, 2017 IntelGenx Technologies Corp. 6420 Abrams Ville Saint-Laurent, Qu?bec H4S 1Y2 Attention: Horst G. Zerbe President and Chief Executive Officer Dear Sir: The undersigned, Desjardins Securities Inc. (the ?Lead Agent?), Laurentian Bank Securities Inc. (?Laurentian?) and Echelon Wealth Partners Inc. (?Ec

IGXT / IntelGenx Technologies Corp. - SEC-arkivering, Årsberetning, Fuldmagtserklæring

Grundlæggende statistik

SEC Filings

SEC Filings (Chronological Order)